These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31752121)

  • 1. Neonatal Mass Urine Screening Approach for Early Detection of Mucopolysaccharidoses by UPLC-MS/MS.
    Menkovic I; Marchand AS; Boutin M; Auray-Blais C
    Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31752121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI.
    Auray-Blais C; Bhérer P; Gagnon R; Young SP; Zhang HH; An Y; Clarke JT; Millington DS
    Mol Genet Metab; 2011 Jan; 102(1):49-56. PubMed ID: 20934363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UPLC-MS/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses.
    Auray-Blais C; Lavoie P; Tomatsu S; Valayannopoulos V; Mitchell JJ; Raiman J; Beaudoin M; Maranda B; Clarke JT
    Anal Chim Acta; 2016 Sep; 936():139-48. PubMed ID: 27566349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A straightforward, quantitative ultra-performance liquid chromatography-tandem mass spectrometric method for heparan sulfate, dermatan sulfate and chondroitin sulfate in urine: an improved clinical screening test for the mucopolysaccharidoses.
    Zhang H; Wood T; Young SP; Millington DS
    Mol Genet Metab; 2015 Feb; 114(2):123-8. PubMed ID: 25458519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Glycosaminoglycans in Urine by Isotope-Dilution Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc; 2023 Mar; 3(3):e701. PubMed ID: 36929617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.
    Kubaski F; Suzuki Y; Orii K; Giugliani R; Church HJ; Mason RW; Dũng VC; Ngoc CT; Yamaguchi S; Kobayashi H; Girisha KM; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2017 Mar; 120(3):247-254. PubMed ID: 28065440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I.
    Polo G; Gueraldi D; Giuliani A; Rubert L; Cazzorla C; Salviati L; Marzollo A; Biffi A; Burlina AP; Burlina AB
    Clin Chem Lab Med; 2020 Nov; 58(12):2063-2072. PubMed ID: 32432561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses.
    Shimada T; Kelly J; LaMarr WA; van Vlies N; Yasuda E; Mason RW; Mackenzie W; Kubaski F; Giugliani R; Chinen Y; Yamaguchi S; Suzuki Y; Orii KE; Fukao T; Orii T; Tomatsu S
    Mol Genet Metab; 2014; 113(1-2):92-9. PubMed ID: 25092413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of glycosaminoglycans in urine by isotope-dilution liquid chromatography-electrospray ionization tandem mass spectrometry.
    Zhang H; Young SP; Millington DS
    Curr Protoc Hum Genet; 2013; Chapter 17():Unit 17.12. PubMed ID: 23315926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
    Kubaski F; Mason RW; Nakatomi A; Shintaku H; Xie L; van Vlies NN; Church H; Giugliani R; Kobayashi H; Yamaguchi S; Suzuki Y; Orii T; Fukao T; Montaño AM; Tomatsu S
    J Inherit Metab Dis; 2017 Jan; 40(1):151-158. PubMed ID: 27718145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy.
    Zhang H; Dickson PI; Stiles AR; Chen AH; Le SQ; McCaw P; Beasley J; Millington DS; Young SP
    Clin Chim Acta; 2020 Sep; 508():179-184. PubMed ID: 32442432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry.
    Tomatsu S; Kubaski F; Sawamoto K; Mason RW; Yasuda E; Shimada T; Montaño AM; Yamaguchi S; Suzuki Y; Orii T
    Nihon Masu Sukuriningu Gakkai Shi; 2014; 24():19-37. PubMed ID: 25620850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn screening for mucopolysaccharidoses: Measurement of glycosaminoglycans by LC-MS/MS.
    Stapleton M; Kubaski F; Mason RW; Shintaku H; Kobayashi H; Yamaguchi S; Taketani T; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab Rep; 2020 Mar; 22():100563. PubMed ID: 31956510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multiplex Assay for the Diagnosis of Mucopolysaccharidoses and Mucolipidoses.
    Langereis EJ; Wagemans T; Kulik W; Lefeber DJ; van Lenthe H; Oussoren E; van der Ploeg AT; Ruijter GJ; Wevers RA; Wijburg FA; van Vlies N
    PLoS One; 2015; 10(9):e0138622. PubMed ID: 26406883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for glycosaminoglycan analysis by LC-MS/MS of urine samples collected on filter paper.
    Auray-Blais C; Lavoie P; Zhang H; Gagnon R; Clarke JT; Maranda B; Young SP; An Y; Millington DS
    Clin Chim Acta; 2012 Apr; 413(7-8):771-8. PubMed ID: 22285314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan.
    Lin HY; Lee CL; Lo YT; Tu RY; Chang YH; Chang CY; Chiu PC; Chang TM; Tsai WH; Niu DM; Chuang CK; Lin SP
    Diagnostics (Basel); 2019 Oct; 9(4):. PubMed ID: 31590383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry.
    Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Barrera LA; Kida K; Kubota M; Orii T
    Mol Genet Metab; 2010 Feb; 99(2):124-31. PubMed ID: 19932038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses.
    Chuang CK; Lin HY; Wang TJ; Tsai CC; Liu HL; Lin SP
    Orphanet J Rare Dis; 2014 Sep; 9():135. PubMed ID: 25178307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.